Antibiotic resistance mediated by site-specific mutations in the multidrug efflux transporter CmeB of zoonotic pathogen Campylobacter

Abstract

The resistance‒nodulation‒division (RND) family of multidrug efflux transporters is widely distributed in Gram-negative bacteria. Although their roles in mediating antibiotic resistance have been well known, our understanding of how they are altered to augment bacterial adaptation to antibiotic selection remains at an infancy stage. Here, we report the identification of a mutation-based mechanism that empowers the function of the CmeB efflux protein, an RND-type transporter in the zoonotic pathogen Campylobacter. During our surveillance study, we identified Campylobacter isolates that were phenotypically resistant to florfenicol but lacked known florfenicol resistance mechanisms. Using natural transformation and whole genome sequencing, we first linked the phenotype to sequence polymorphisms in the cmeB and subsequently demonstrated that both the T136A and M292I mutations in CmeB are required for the resistance phenotype. The mutations elevated Campylobacter resistance to florfenicol, ciprofloxacin, and other classes of antimicrobial agents. Structural modeling and molecular dynamics simulations revealed that the two residues were localized in the drug-binding pocket of CmeB, and the T136A and M292I substitutions enhanced hydrophobic interactions, stabilized CmeB-antibiotic binding, and lessened steric hindrance in the drug-binding pocket, thereby facilitating antibiotic extrusion by CmeB. Analysis of the Campylobacter genomic sequences deposited in the NCBI database revealed that T136A- and M292I-harboring isolates were found in 35 different countries and associated with various host species, indicating the widespread distribution and clinical relevance of the two mutations. Together, these results identified a new mechanism underlying CmeB-mediated multidrug resistance and provide a potential target for clinical surveillance of antibiotic-resistant Campylobacter.

Keywords

antibiotic resistance / Campylobacter / CmeABC / efflux transporter / foodborne diseases

References

[1] Blair JM, Richmond GE, Piddock LJ. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014; 9: 1165–1177.

[2] Du D, Wang-Kan X, Neuberger A, van Veen HW, Pos KM, Piddock LJV, et al. Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol. 2018; 16: 523–539.

[3] Zwama M, Yamaguchi A. Molecular mechanisms of AcrB-mediated multidrug export. Res Microbiol. 2018; 169: 372–383.

[4] Du D, Wang Z, James NR, Voss JE, Klimont E, Ohene-Agyei T, et al. Structure of the AcrAB-TolC multidrug efflux pump. Nature. 2014; 509: 512–515.

[5] Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015; 28: 337–418.

[6] Blair JMA, Bavro VN, Ricci V, Modi N, Cacciotto P, Kleinekathӧfer U, et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc Natl Acad Sci USA. 2015; 112: 3511–3516.

[7] Ma KC, Mortimer TD, Grad YH. Efflux pump antibiotic binding site mutations are associated with azithromycin nonsusceptibility in clinical Neisseria gonorrhoeae isolates. mBio. 2020; 11:e01509-20.

[8] McNulty CM, Wise R. Rapid diagnosis of Campylobacter-associated gastritis. Lancet. 1985; 325: 1443–1444.

[9] Sahin O, Yaeger M, Wu Z, Zhang Q. Campylobacter-associated diseases in animals. Ann Rev Anim Biosci. 2017; 5: 21–42.

[10] Blaser MJ, Reller LB. Campylobacter enteritis. N Engl J Med. 1981; 305: 1444–1452.

[11] Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015; 28: 687–720.

[12] Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 2009; 4: 189–200.

[13] Shen Z, Wang Y, Zhang Q, Shen J. Antimicrobial resistance in Campylobacter spp. Microbiol Spectr. 2018; 6: 10.

[14] Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother. 2002; 46: 2124–2131.

[15] Vieira A, Ramesh A, Seddon AM, Karlyshev AV. CmeABC multidrug efflux pump contributes to antibiotic resistance and promotes Campylobacter jejuni survival and multiplication in Acanthamoeba polyphaga. Appl Environ Microbiol. 2017; 83:e01600-17.

[16] Akiba M, Lin J, Barton YW, Zhang Q. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J Antimicrob Chemother. 2006; 57: 52–60.

[17] Lin J, Cagliero C, Guo B, Barton YW, Maurel MC, Payot S, et al. Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol. 2005; 187: 7417–7424.

[18] Guo B, Lin J, Reynolds DL, Zhang Q. Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different Campylobacter species. Foodborne Pathog Dis. 2010; 7: 77–83.

[19] Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun. 2003; 71: 4250–4259.

[20] Sharifi S, Bakhshi B, Najar-Peerayeh S. Significant contribution of the CmeABC efflux pump in high-level resistance to ciprofloxacin and tetracycline in Campylobacter jejuni and Campylobacter coli clinical isolates. Ann Clin Microbiol Antimicrob. 2021; 20: 36.

[21] Gibreel A, Wetsch NM, Taylor DE. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 2007; 51: 3212–3216.

[22] Ge B, McDermott PF, White DG, Meng J. Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 2005; 49: 3347–3354.

[23] Luo N, Sahin O, Lin J, Michel LO, Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother. 2003; 47: 390–394.

[24] Lin J, Akiba M, Sahin O, Zhang Q. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother. 2005; 49: 1067–1075.

[25] Cagliero C, Maurel MC, Cloeckaert A, Payot S. Regulation of the expression of the CmeABC efflux pump in Campylobacter jejuni: identification of a point mutation abolishing the binding of the CmeR repressor in an in vitro-selected multidrug-resistant mutant. FEMS Microbiol Lett. 2007; 267: 89–94.

[26] Yao H, Shen Z, Wang Y, Deng F, Liu D, Naren G, et al. Emergence of a potent multidrug efflux pump variant that enhances Campylobacter resistance to multiple antibiotics. mBio. 2016; 7:e01543-16.

[27] Schiaffino F, Parker CT, Paredes Olortegui M, Pascoe B, Manzanares Villanueva K, Garcia Bardales PF, et al. Genomic resistant determinants of multidrug-resistant Campylobacter spp. isolates in Peru. J Glob Antimicrob Resist. 2024; 36: 309–318.

[28] Yao H, Zhao W, Jiao D, Schwarz S, Zhang R, Li X. Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni. J Antimicrob Chemother. 2021; 76: 596–600.

[29] Zhang Z, Lizer N, Wu Z, Morgan CE, Yan Y, Zhang Q, et al. Cryo-electron microscopy structures of a Campylobacter multidrug efflux pump reveal a novel mechanism of drug recognition and resistance. Microbiol Spectr. 2023; 11:e0119723.

[30] Yang L, Shi H, Zhang L, Lin X, Wei Y, Jiang H, et al. Emergence of two AcrB substitutions conferring multidrug resistance to Salmonella spp. Antimicrob Agents Chemother. 2023; 65:e01589-20.

[31] Lau CHF, Hughes D, Poole K. MexY-promoted aminoglycoside resistance in Pseudomonas aeruginosa: involvement of a putative proximal binding pocket in aminoglycoside recognition. mBio. 2014; 5:e01068.

[32] Cagliero C, Mouline C, Cloeckaert A, Payot S. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother. 2006; 50: 3893–3896.

[33] Su CC, Yin L, Kumar N, Dai L, Radhakrishnan A, Bolla JR, et al. Structures and transport dynamics of a Campylobacter jejuni multidrug efflux pump. Nat Commun. 2017; 8: 171.

[34] Oswald C, Tam HK, Pos KM. Transport of lipophilic carboxylates is mediated by transmembrane helix 2 in multidrug transporter AcrB. Nat Commun. 2016; 7:13819.

[35] Nakashima R, Sakurai K, Yamasaki S, Nishino K, Yamaguchi A. Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature. 2011; 480: 565–569.

[36] Bolla JR, Su CC, Do SV, Radhakrishnan A, Kumar N, Long F, et al. Crystal structure of the Neisseria gonorrhoeae MtrD inner membrane multidrug efflux pump. PLoS One. 2014; 9:e97903.

[37] Eicher T, Cha H, Seeger MA, Brandstätter L, El-Delik J, Bohnert JA, et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci USA. 2012; 109: 5687–5692.

[38] Zwama M, Nishino K. Ever-adapting RND efflux pumps in Gram-negative multidrug-resistant pathogens: a race against time. Antibiotics. 2021; 10: 774.

[39] Hooda Y, Sajib MSI, Rahman H, Luby SP, Bondy-Denomy J, Santosham M, et al. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance. PLoS Neglected Trop Dis. 2019; 13:e0007868.

[40] Sajib MSI, Tanmoy AM, Hooda Y, Rahman H, Andrews JR, Garrett DO, et al. Tracking the emergence of azithromycin resistance in multiple genotypes of typhoidal Salmonella. mBio. 2021; 12:e03481-20.

[41] Hwang S, Zhang Q, Ryu S, Jeon B. Transcriptional regulation of the CmeABC multidrug efflux pump and the KatA catalase by CosR in Campylobacter jejuni. J Bacteriol. 2012; 194: 6883–6891.

[42] Grinnage-Pulley T, Mu Y, Dai L, Zhang Q. Dual repression of the multidrug efflux pump CmeABC by CosR and CmeR in Campylobacteri jejuni. Front Microbiol. 2016; 7: 1097.

[43] Routh MD, Su CC, Zhang Q, Yu EW. Structures of AcrR and CmeR: insight into the mechanisms of transcriptional repression and multi-drug recognition in the TetR family of regulators. Biochim Biophys Acta BBA Proteins Proteom. 2009; 1794: 844–851.

[44] Grinnage-Pulley T, Zhang Q. Genetic basis and functional consequences of differential expression of the CmeABC efflux pump in Campylobacter jejuni isolates. PLoS One. 2015; 10:e013153.

[45] Yao H, Shen Z, Wang Y, Deng F, Liu D, Naren G, et al. Emergence of a potent multidrug efflux pump variant that enhances Campylobacter resistance to multiple antibiotics. mBio. 2016; 7:e01543-16.

[46] Montgomery MP, Robertson S, Koski L, Salehi E, Stevenson LM, Silver R, et al. Multidrug-resistant Campylobacter jejuni outbreak linked to puppy exposure—United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 2018; 67: 1032–1035.

[47] Dai L, Wu Z, Sahin O, Zhao S, Yu EW, Zhang Q. Mutation-based mechanism and evolution of the potent multidrug efflux pump RE-CmeABC in Campylobacter. Proc Natl Acad Sci USA. 2024; 121:e2415823121.

[48] Murakami S, Nakashima R, Yamashita E, Matsumoto T, Yamaguchi A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature. 2006; 443: 173–179.

[49] Tang Y, Lai Y, Yang X, Cao X, Hu Y, Wang X, et al. Genetic environments and related transposable elements of novel cfr(C) variants in Campylobacter coli isolates of swine origin. Vet Microbiol. 2020; 247:108792.

[50] CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.

[51] Wang Y, Taylor DE. Natural transformation in Campylobacter species. J Bacteriol. 1990; 172: 949–955.

[52] Tang Y, Fang L, Xu C, Zhang Q. Antibiotic resistance trends and mechanisms in the foodborne pathogen, Campylobacter. Anim Health Res Rev. 2017; 18: 87–98.

[53] Demond H, Hanna CW, Castillo-Fernandez J, Santos F, Papachristou EK, Segonds-Pichon A, et al. Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis. Genome Res. 2023; 33: 18–31.

[54] Kechin A, Boyarskikh U, Kel A, Filipenko M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J Comput Biol. 2017; 24: 1138–1143.

[55] Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using sPAdes de novo assembler. Curr Protoc Bioinformatics. 2020; 70:e102.

[56] Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017; 13:e1005595.

[57] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25: 402–408.

[58] Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021; 38: 3022–3027.

[59] Webb B, Sali A. Comparative protein structure modeling using MODELLER. Curr Protoc Bioinformatics. 2016; 54: 561–5637.

[60] Yang X, Liu Y, Gan J, Xiao ZX, Cao Y. FitDock: protein-ligand docking by template fitting. Brief. Bioinform. 2022; 23:bbac087.

[61] O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminf. 2011; 3: 33.

[62] Wang J, Wang W, Kollman PA, Case DA. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model. 2006; 25: 247–260.

[63] Pall S, Zhmurov A, Bauer P, Gray A, Hess B, Lindahl E, et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J Chem Phys. 2020; 153:134110.

[64] Kumari R, Kumar R, Lynn A. g_mmpbsa—a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014; 54: 1951–1962.

[65] Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graphics. 1996; 14: 33–38.

[66] Skjærven L, Yao XQ, Scarabelli G, Grant BJ. Integrating protein structural dynamics and evolutionary analysis with Bio3D. BMC Bioinformatics. 2014; 15: 399.

RIGHTS & PERMISSIONS

2026 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.